Delta Financial Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Delta Financial Advisors's VRTX Position: Q2 2026 in Review
Delta Financial Advisors held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 863 shares worth $429K. The position accounts for 0.1% of the portfolio, ranked #119.
Delta Financial Advisors first reported a position in VRTX in Q2 2023 and has held it in 13 quarters since. 1,761 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Delta Financial Advisors held 863 shares of Vertex Pharmaceuticals worth $429K as of Q2 2026.
- Delta Financial Advisors left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
- Vertex Pharmaceuticals made up 0.1% of Delta Financial Advisors's portfolio in Q2 2026, its #119 holding.
- Delta Financial Advisors first reported a position in Vertex Pharmaceuticals in Q2 2023 and has held it in 13 quarters since.
- 1,761 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Delta Financial Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.